German Authorities Accuse India's Alkem Laboratories of Fudging Data in Clinical Trials

Shares in India's Alkem Laboratories Ltd fell as much as 8 percent on Monday after the company confirmed it was in talks with German authorities who had accused it of fudging data in some clinical trials.

Reuters reported on Friday that German authorities had accused the company of manipulating heart readings of patients in some trials for the antibiotic cefuroxime and the brain disorder drug rulizole, following an inspection of Alkem's plant in Taloja in western India in March 2015.

The European Medicines Agency (EMA) is investigating the medicines after Germany reported its findings to the EMA and urged it to take action in a report that was posted on the EMA website.

Back to news